#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phenylketonuria Amyotrophic lateral sclerosis Plasma cell myeloma refractory Infertility female Anaplastic thyroid cancer Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Alpha-1 antitrypsin deficiency Haemophagocytic lymphohistiocytosis Encephalitis autoimmune Squamous cell carcinoma of the cervix Sjogren's syndrome Proteus syndrome Infertility male Nasopharyngeal cancer Amyloidosis More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma – Basic Information Paroxysmal nocturnal haemoglobinuria – Life with Disease Marginal zone lymphoma refractory – Diagnostics Angiosarcoma Hereditary hypophosphataemic rickets – Trials in Disease Hyperoxaluria – Life with Disease Angiosarcoma non-metastatic – Trials in Disease Breast angiosarcoma – Life with Disease Antithrombin III deficiency – Trials in Disease Pelizaeus-Merzbacher disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sar444656 Medroxyprogesterone Acetate Buclizine Hydrochloride DROSPIRENONE 64Cu-Dota-Ae105 IADADEMSTAT Insulin Glargine Anakinra Rbl005.3 Losmapimod Sodium Chloride Alisertib Sodium SEVUPARIN Deoxyribonucleic Acid Taminadenant Nelivaptan Tofersen Ferumoxytol Rtp-026 Sodium Rbl015.2 More therapies…

    Learn about Your Condition

    Pemphigoid Type 1 diabetes mellitus Factor VIII deficiency Hepatoblastoma Diabetic foot infection Alveolar rhabdomyosarcoma Hypopituitarism Mucopolysaccharidosis III Thyroid cancer metastatic Femoral neck fracture Cystic fibrosis lung Neurodegenerative disorder Tumour thrombosis Postprandial hypoglycaemia Haemorrhage intracranial More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Safety and tolerability study of sodium hydrogen carbonate and sodium dihydrogen phosphate suppository treatment in adult patients with chronic constipation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Constipation
    Investigated Drugs:
    • SODIUM DIHYDROGEN PHOSPHATE
    • Sodium Hydrogen Carbonate
    Germany
  • Safety Study of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Patients with Metastatic Colorectal or Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Colorectal cancer metastatic
    • Prostate cancer
    Investigated Drugs:
    • Aldesleukin
    • Mesna
    • Cyclophosphamide Monohydrate
    Germany
  • Evaluation of Choline Chloride for Intestinal Failure Patients Receiving Long-Term Parenteral Support

    Recruiting

    4 1
    Belgium Denmark France Germany Poland
  • Study on Reduction of Toxicant Levels in Blood through Combined Digestive Decontamination with Activated Charcoal and Intestinal Purge for Intubated Patients with Major Poisoning in Intensive Care

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Charcoal, Activated
    • Macrogol 4000
    • Sodium Hydrogen Carbonate
    France
  • Efficacy of 177Lu-DOTATATE as Adjuvant Therapy After Surgery for Stage III Small Intestinal Neuroendocrine Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small intestine neuroendocrine tumour
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    Germany
  • Study of Belatacept versus Tacrolimus in Kidney Transplant Recipients with Subclinical Antibody Mediated Rejection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Belatacept
    • Tacrolimus
    France
Previous Page
1 … 8 9 10 11 12 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!